These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33249763)

  • 1. An application of the mixed-effects model and pattern mixture model to treatment groups with differential missingness suspected not-missing-at-random.
    Gosho M; Maruo K
    Pharm Stat; 2021 Jan; 20(1):93-108. PubMed ID: 33249763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets.
    Siddiqui O; Hung HM; O'Neill R
    J Biopharm Stat; 2009; 19(2):227-46. PubMed ID: 19212876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian pattern-mixture models for dropout and intermittently missing data in longitudinal data analysis.
    Blozis SA
    Behav Res Methods; 2024 Mar; 56(3):1953-1967. PubMed ID: 37221346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of heteroscedasticity between treatment groups on mixed-effects models for repeated measures.
    Gosho M; Maruo K
    Pharm Stat; 2018 Sep; 17(5):578-592. PubMed ID: 29978944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of pattern mixture models to address missing data in longitudinal data analysis using SPSS.
    Son H; Friedmann E; Thomas SA
    Nurs Res; 2012; 61(3):195-203. PubMed ID: 22551994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Two-Step Approach for Analysis of Nonignorable Missing Outcomes in Longitudinal Regression: an Application to Upstate KIDS Study.
    Liu D; Yeung EH; McLain AC; Xie Y; Buck Louis GM; Sundaram R
    Paediatr Perinat Epidemiol; 2017 Sep; 31(5):468-478. PubMed ID: 28767145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mixed model for repeated measures for cluster randomized trials: a simulation study investigating bias and type I error with missing continuous data.
    Bell ML; Rabe BA
    Trials; 2020 Feb; 21(1):148. PubMed ID: 32033617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A note on the bias of standard errors when orthogonality of mean and variance parameters is not satisfied in the mixed model for repeated measures analysis.
    Maruo K; Ishii R; Yamaguchi Y; Doi M; Gosho M
    Stat Med; 2020 Apr; 39(9):1264-1274. PubMed ID: 31916260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the multiple imputation variance estimator for control-based and delta-adjusted pattern mixture models.
    Tang Y
    Biometrics; 2017 Dec; 73(4):1379-1387. PubMed ID: 28407203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of pattern-mixture models in randomized clinical trials.
    Bunouf P; Molenberghs G
    Pharm Stat; 2016 Nov; 15(6):494-506. PubMed ID: 27658505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An application of a pattern-mixture model with multiple imputation for the analysis of longitudinal trials with protocol deviations.
    Iddrisu AK; Gumedze F
    BMC Med Res Methodol; 2019 Jan; 19(1):10. PubMed ID: 30626328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of overall treatment effect in MMRM.
    Song T; Dong Q; Sankoh AJ; Molenberghs G
    J Biopharm Stat; 2013; 23(6):1281-93. PubMed ID: 24138432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of an incomplete longitudinal composite variable using a marginalized random effects model and multiple imputation.
    Gosho M; Maruo K; Ishii R; Hirakawa A
    Stat Methods Med Res; 2018 Jul; 27(7):2200-2215. PubMed ID: 27856962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous(ly) missing outcome data in network meta-analysis: A one-stage pattern-mixture model approach.
    Spineli LM; Kalyvas C; Papadimitropoulou K
    Stat Methods Med Res; 2021 Apr; 30(4):958-975. PubMed ID: 33406990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An extension of the placebo-based pattern-mixture model.
    Lu K
    Pharm Stat; 2014; 13(2):103-9. PubMed ID: 24343870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-Response Mixed Models for Repeated Measures - a New Method for Assessment of Dose-Response.
    Wellhagen GJ; Hamrén B; Kjellsson MC; Åstrand M
    Pharm Res; 2020 Jul; 37(8):157. PubMed ID: 32737604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single time point comparisons in longitudinal randomized controlled trials: power and bias in the presence of missing data.
    Ashbeck EL; Bell ML
    BMC Med Res Methodol; 2016 Apr; 16():43. PubMed ID: 27068578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMRM vs joint modeling of longitudinal responses and time to study drug discontinuation in clinical trials using a "de jure" estimand.
    García-Hernandez A; Pérez T; Pardo MDC; Rizopoulos D
    Pharm Stat; 2020 Nov; 19(6):909-927. PubMed ID: 32725810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing missing data assumptions in longitudinal studies: an example using a smoking cessation trial.
    Yang X; Shoptaw S
    Drug Alcohol Depend; 2005 Mar; 77(3):213-25. PubMed ID: 15734221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A semi-parametric shared parameter model to handle nonmonotone nonignorable missingness.
    Tsonaka R; Verbeke G; Lesaffre E
    Biometrics; 2009 Mar; 65(1):81-7. PubMed ID: 18373713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.